Fiduciary Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.89M | Buy |
24,044
+4,326
| +22% | +$499K | 0.25% | 87 |
|
|
2025
Q4 | $2.08M | Sell |
19,718
-1,303
| -6% | -$122K | 0.17% | 105 |
|
|
2025
Q3 | $1.76M | Sell |
21,021
-344
| -2% | -$28.3K | 0.16% | 119 |
|
|
2025
Q2 | $1.69M | Sell |
21,365
-256
| -1% | -$20.3K | 0.16% | 115 |
|
|
2025
Q1 | $1.94M | Sell |
21,621
-162
| -0.7% | -$15.1K | 0.19% | 106 |
|
|
2024
Q4 | $2.17M | Sell |
21,783
-806
| -4% | -$83.1K | 0.22% | 97 |
|
|
2024
Q3 | $2.57M | Sell |
22,589
-929
| -4% | -$110K | 0.26% | 90 |
|
|
2024
Q2 | $2.91M | Sell |
23,518
-714
| -3% | -$92K | 0.31% | 78 |
|
|
2024
Q1 | $3.2M | Buy |
24,232
+2,101
| +9% | +$259K | 0.35% | 71 |
|
|
2023
Q4 | $2.41M | Sell |
22,131
-1,147
| -5% | -$119K | 0.28% | 80 |
|
|
2023
Q3 | $2.4M | Sell |
23,278
-630
| -3% | -$67.9K | 0.31% | 75 |
|
|
2023
Q2 | $2.76M | Sell |
23,908
-597
| -2% | -$67.8K | 0.34% | 74 |
|
|
2023
Q1 | $2.61M | Sell |
24,505
-50
| -0.2% | -$5.4K | 0.34% | 75 |
|
|
2022
Q4 | $2.72M | Buy |
24,555
+1,075
| +5% | +$110K | 0.36% | 71 |
|
|
2022
Q3 | $2.39M | Sell |
23,480
-77
| -0.3% | -$6.87K | 0.31% | 77 |
|
|
2022
Q2 | $2.1M | Buy |
23,557
+136
| +0.6% | +$12.1K | 0.26% | 80 |
|
|
2022
Q1 | $2.09M | Buy |
23,421
+436
| +2% | +$34.4K | 0.28% | 76 |
|
|
2021
Q4 | $1.76M | Buy |
22,985
+446
| +2% | +$35.5K | 0.2% | 88 |
|
|
2021
Q3 | $1.85M | Buy |
22,539
+133
| +0.6% | +$10.1K | 0.21% | 81 |
|
|
2021
Q2 | $1.69M | Sell |
22,406
-1,191
| -5% | -$88.6K | 0.2% | 85 |
|
|
2021
Q1 | $1.68M | Sell |
23,597
-787
| -3% | -$58.1K | 0.2% | 87 |
|
|
2020
Q4 | $1.74M | Sell |
24,384
-225
| -0.9% | -$17.2K | 0.23% | 79 |
|
|
2020
Q3 | $1.95M | Sell |
24,609
-830
| -3% | -$65K | 0.29% | 73 |
|
|
2020
Q2 | $1.88M | Buy |
25,439
+350
| +1% | +$26.3K | 0.31% | 67 |
|
|
2020
Q1 | $1.84M | Sell |
25,089
-652
| -3% | -$51.2K | 0.36% | 60 |
|
|
2019
Q4 | $2.23M | Sell |
25,741
-559
| -2% | -$45.9K | 0.36% | 61 |
|
|
2019
Q3 | $2.11M | Sell |
26,300
-671
| -2% | -$53.8K | 0.37% | 59 |
|
|
2019
Q2 | $2.16M | Sell |
26,971
-1,307
| -5% | -$100K | 0.39% | 56 |
|
|
2019
Q1 | $2.24M | Buy |
28,278
+328
| +1% | +$24.5K | 0.42% | 56 |
|
|
2018
Q4 | $2.04M | Sell |
27,950
-281
| -1% | -$19.8K | 0.42% | 57 |
|
|
2018
Q3 | $1.91M | Sell |
28,231
-639
| -2% | -$40.7K | 0.37% | 61 |
|
|
2018
Q2 | $1.67M | Sell |
28,870
-2,050
| -7% | -$116K | 0.35% | 63 |
|
|
2018
Q1 | $1.61M | Sell |
30,920
-895
| -3% | -$48.3K | 0.35% | 70 |
|
|
2017
Q4 | $1.71M | Sell |
31,815
-2,181
| -6% | -$121K | 0.36% | 70 |
|
|
2017
Q3 | $2.08M | Sell |
33,996
-597
| -2% | -$36.2K | 0.47% | 60 |
|
|
2017
Q2 | $2.12M | Sell |
34,593
-1,280
| -4% | -$77.9K | 0.49% | 60 |
|
|
2017
Q1 | $2.17M | Sell |
35,873
-1,989
| -5% | -$121K | 0.52% | 60 |
|
|
2016
Q4 | $2.13M | Sell |
37,862
-2,065
| -5% | -$121K | 0.55% | 57 |
|
|
2016
Q3 | $2.38M | Buy |
39,927
+14
| +0% | +$819 | 0.64% | 51 |
|
|
2016
Q2 | $2.19M | Buy |
39,913
+1,026
| +3% | +$54.6K | 0.61% | 55 |
|
|
2016
Q1 | $1.96M | Sell |
38,887
-109
| -0.3% | -$5.34K | 0.57% | 55 |
|
|
2015
Q4 | $1.97M | Buy |
38,996
+2,881
| +8% | +$145K | 0.59% | 54 |
|
|
2015
Q3 | $1.7M | Sell |
36,115
-239
| -0.7% | -$12.7K | 0.57% | 57 |
|
|
2015
Q2 | $1.98M | Buy |
+36,354
| New | +$2.04M | 0.62% | 52 |
|
Other funds holding MRK
VCM
VPM
Fiduciary Group's MRK Position: Q1 2026 in Review
Fiduciary Group increased its Merck (MRK) stake by 22% in Q1 2026, buying an estimated $499K and bringing the position to 24,044 shares worth $2.89M. The position accounts for 0.25% of the portfolio, ranked #87.
Fiduciary Group first reported a position in MRK in Q2 2015 and has held it in 44 quarters since. The position peaked at $3.2M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Fiduciary Group held 24,044 shares of Merck worth $2.89M as of Q1 2026.
- Fiduciary Group bought 4,326 Merck shares in Q1 2026, an estimated $499K.
- Merck made up 0.25% of Fiduciary Group's portfolio in Q1 2026, its #87 holding.
- Fiduciary Group first reported a position in Merck in Q2 2015 and has held it in 44 quarters since.
- Fiduciary Group's Merck position peaked at $3.2M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.